Par Drugs & Chemicals Ltd

NSE : PAR

BSE: 535341

SECTOR : PHARMACEUTICALS

This stock is currently not listed in BSE

52w high/low	₹310.6 / ₹31.2
P/E ratio	15.45
Dividend	0
ROE	18.88
ROCE	25.49
Face value	10
Book value	₹78.64Cr
Market capital	₹282.27Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.

Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:

Assets = Liabilities + Shareholder's Equity

This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

PE TTM

15.45

P/B

2.92

ROE

18.88

ROCE

25.49

EPS TTM

14.85

EBTIDA Growth

25.05

Sector PE

47.28

₹78.64Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited was originally incorporated as a private limited company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat. On 26 February 1999. Subsequently, the company was converted into a public limited company pursuant to special resolution passed by the members in extra-ordinary general meeting of the company held on October 24, 2018 and the name of the company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. Vallabhbhai Savani and Sarita Savani were initial subscribers to the Memorandum of Association of the company. The Promoters of the company are Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani. The Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani have first shares on 19, 2006 through allotment of shares by company. The Company is engaged in the development and manufacture of Active Pharma ingredients ('APIs') for the domestic market as well as for exports to international markets. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.